ECP expression levels furthermore were increased in both the inflamed mucosa and deeper layers, in comparison with the non-IBD controls (P = 0.004 and P = 0.0005) and the CD unaffected area (P = 0.04 and P = 0.02). Here, RNASE3 is linked to inflammatory bowel disease.